{"id":9963,"date":"2016-10-28T06:00:00","date_gmt":"2016-10-28T06:00:00","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/heliospectra-ab-publ-interim-management-statement-january-september-2016\/"},"modified":"2016-10-28T06:00:00","modified_gmt":"2016-10-28T06:00:00","slug":"heliospectra-ab-publ-interim-management-statement-january-september-2016","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/nl\/blog\/mfn_news\/heliospectra-ab-publ-interim-management-statement-january-september-2016\/","title":{"rendered":"Heliospectra AB (publ) Interim Management Statement January – September 2016"},"content":{"rendered":"
Turnover and profit\/loss January – September<\/strong><\/p>\n Significant events<\/strong><\/p>\n Januari – March<\/em><\/p>\n April – June<\/em><\/p>\n July – September<\/em><\/p>\n Events after the end of the period<\/strong><\/p>\n A Word From the CEO<\/span><\/strong><\/p>\n Dear shareholders of Heliospectra AB<\/span> (publ),<\/p>\n The market for medicinal plants continues to develop rapidly. On top of the 23 states in the US<\/span> where growing medicinal cannabis has been legalized, another handful are set to rule on this decision in the near future. In Australia it will be implemented by November according to a recent ruling. We are observing a global trend. Turkey has recently ruled to legalize controlled production in 19 provinces. Earlier this year Macedonia legalized use for medicinal purposes. These types of discussions are going around many other European countries, where it is already possible to buy approved prescribed substances in pharmacies. We can see this same trend in Latin America, where Uruguay is one of the countries that has taken the lead. <\/p>\n There are a number of important driving forces behind Heliospectra’s technology. FAO<\/span> recently stated that climate change related to farming is already considerable, while at the same time the demand for food will increase by at least 60% by 2050. We have a situation involving a growing population and increasing urbanization. To be able handle this situation the production methods need to be improved and concede to an increased level of automation. This also drives agricultural technology companies – who develop and sell seeds, pesticides and fertilizer – to invest in new technology. Furthermore, the actual production will have to take place closer to the consumer, which accelerates the growth of “city farming” and cuts down on logistical flows. We are counting on significant changes being made to the entire value chain in the years to come. <\/p>\n The company’s positive development continues. Compared to the same period last year we have increased our revenues by 160 %. We can also enjoy a testimony to the confidence our customers place in us when one of the world’s leading agricultural technology company places their fourth order for another 1.9 MSEK<\/span>. <\/p>\n To continue to finance our expansion on the market, the company’s board has suggested a preferential rights issue of approx. 91MSEK<\/span>, with the possibility of an over allocation of approx. 20MSEK<\/span>. It is very positive that our principal owners support the company and have committed to subscribe, while also making sure that the entire rights issue is fully underwritten. The raised capital mainly relates to operating capital for sales and marketing, continued product development and to strengthen the balance sheet. <\/p>\n With rapidly growing markets, world leading products and strong principal owners backing us we can look positively to the future. <\/p>\n Staffan Hillberg, CEO<\/span> For the full report: http:\/\/ir.heliospectra.com\/en\/financial-reports\/<\/span><\/a><\/p>\n\n
\n
\n
\n
\n
Heliospectra AB<\/span> (publ)<\/p>\n